Merck & Co., Inc. (NYSE:MRK) is included among the Billionaire Ken Fisher’s Top 11 Dividend Stock Picks. Reuters reported on ...

The approvals are based on a Phase 3 study that showed the Keytruda-Welireg combo cut the risk of the cancer coming back, spreading or death by 28% compared with Keytruda plus pla ...

Merck (MRK) stock is in focus as the FDA approves a label expansion for the company's kidney cancer drug Welireg with its ...

Gilead’s lenacapavir has been on the market since 2022, when it was approved in the U.S. as Sunlenca for twice-yearly ...

Gilead Sciences Inc. and Merck & Co. said an experimental long acting pill combining two HIV medicines had met its primary ...

Trodelvy's latest setback carries implications for a newly important Merck drug, while the success of a once-weekly HIV ...

Merck (NYSE:MRK) announced a partnership with The Hashgraph Group to build digital product traceability tools aligned with ...

The FDA said Friday that Merck's anti-COVID-19 pill is effective in treating the virus but said that regulators will meet next week to investigate whether the pill is safe for people who are pregnant ...

WASHINGTON (AP) — U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections. The Food and ...